IRCT20200105046010N13尚未招募未知
Pharmacokinetic evaluation and formulation of Ranolazine tablets in comparison with brand drug (RANEXA).
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health (liver, heart, kidney)
- •Body Mass Index (BMI) between 18-28
- •Informed consent
- •Age between 18-60
- •Both male and female
排除标准
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic profile of rapid-acting insulin injected by needle-free jet-injection - Pharmacology of insulin injected with jet-injectioMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitustype 1 diabetes mellitusEUCTR2009-015398-11-NLRadboud University Nijmegen Medical Centre48
已完成
不适用
Pharmacokinetic and pharmacodynamic profile of rapid-acting insulin injected by needle-free jet-injectiojuvenile diabetes10018424type 1 diabetes mellitusNL-OMON32491niversitair Medisch Centrum Sint Radboud48
已完成
不适用
Pharmacokinetic and pharmacodynamic modelling of routinely used off label drugs in premature neonates10039911Pijn en sedatiePrematurity10028971NL-OMON44214Erasmus MC, Universitair Medisch Centrum Rotterdam600
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
进行中（未招募）
1 期
Is treatment with the painkiller paracetamol safe in patients with spinal muscular atrophy and cerebral palsy?Spinal muscular atrophy type II (SMA II)Cerebral palsy (CP)EUCTR2018-002295-40-DKCopenhagen Neuromuscular Center24